Pleural mesothelioma is a rare and aggressive cancer that is linked to asbestos exposure. It affects the lining of the lungs. Every year, there are over 2,500 people in the United Kingdom that are diagnosed with the cancer. A study known as MARS 2 investigated if adding surgery to chemotherapy[…]
Asbestos & Mesothelioma Studies
Pleural Empyema After Pleural Mesothelioma Surgery
Pleural mesothelioma, a cancer linked to asbestos exposure, is challenging to treat. For patients healthy enough, surgery is a key part of treatment, but after surgery, complications can occur. One complication that can happen is known as pleural empyema, a serious chest infection. Developing this complication can affect patient recovery.[…]
Importance of Early Detection of Mesothelioma
Malignant mesothelioma is an aggressive cancer mainly caused by asbestos exposure. It mainly affects the pleura, which is the lining of the lungs, but it can also affect the peritoneum, which is the lining of the abdomen. It is very tough for doctors to diagnose, leading to underdiagnosis. A recent[…]
Gene Expression’s Relationship with Pleural Mesothelioma
Alterations in DNA of patients exposed to asbestos can lead to gene expression, which explains the development of malignant pleural mesothelioma, a rare and aggressive cancer. Scientists were able to analyze public RNA-seq data through a comprehensive bioinformatics pipeline. This led to researchers being able to develop a view of[…]
CRS and HIPEC for Peritoneal Mesothelioma
Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article explains cytoreductive surgery and HIPEC for the treatment of peritoneal mesothelioma. Cytoreductive surgery removes as many tumors as possible. In[…]
Analysis of 70 Mesothelioma Cases
Malignant pleural mesothelioma is a severe cancer mainly caused by asbestos exposure. It often appears decades after exposure. Early on, symptoms can be unclear, making it difficult to diagnose. Even though the cancer is rare, a mesothelioma diagnosis is still concerning since there is a lack of treatment options. An[…]
PORT-7 for the Treatment of Mesothelioma
Results from a clinical trial being performed on malignant pleural mesothelioma patients will be presented at the American Association for Cancer Research meeting being held in Chicago, Illinois. Results will be posted by internationally known mesothelioma expert Dr. Luciano Mutti of the department of Applied Clinical Sciences and Biotechnology at[…]
Blood Biomarkers for Mesothelioma
A mesothelioma diagnosis is hard to receive and can be very overwhelming. Different research outcomes can help doctors and patients make better decisions though. One area of research is blood-based biomarkers. Two biomarkers that can help monitor mesothelioma include mesothelin-related protein (SMRP) and cancer antigen 125 (CA-125). They help monitor[…]
Chrysotile Asbestos Carcinogenesis
Mesothelioma, a tough to treat and severe cancer mainly caused by asbestos, continues to be a global health and safety issue. Chrysotile, the most abundant form of asbestos, is especially harmful due to how prevalent it is. Researchers looked at chrysotile and the heat-treated form forsterite to find the best[…]
Improving Mesothelioma Diagnosis
Malignant mesothelioma, an aggressive cancer mainly caused by asbestos, mainly affects the pleura, the lining of the lungs. It also affects the peritoneum, which is the lining of the abdomen. It is very tough to diagnose mesothelioma, which leads to underdiagnosis of the disease. A study in Brazil’s Sao Paulo[…]
